Effects of laparoscopic sleeve gastrectomy on non-alcoholic steatohepatitis and liver fibrosis in Japanese patients with severe obesity
Obesity Surgery Mar 09, 2020
Nikai H, Ishida K, Umemura A, et al. - The metabolic and histological effects of laparoscopic sleeve gastrectomy (LSG) on non-alcoholic steatohepatitis (NASH) and liver fibrosis in Japanese patients with severe obesity were investigated. Among 79 patients with severe obesity who underwent LSG between June 2008 and March 2019, 43 patients (63.2%) had NASH, and 10 patients had fibrosis without steatosis (a unique feature) at the time of LSG. Among 28 patients with NASH, 25 exhibited improvement and no longer fitted the diagnostic criteria of NASH at 12 months after LSG. In multivariate analysis, HbA1c was identified as the only preoperative predictor of improvement in fibrosis. Outcomes suggest the great potential of LSG as an effective treatment for patients with NASH.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries